2023 Q2 Form 10-Q Financial Statement

#000121390023038588 Filed on May 11, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q4
Revenue $40.00K $37.86K $265.9K
YoY Change -39.77% -77.06% -55.47%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $1.924M $3.276M $3.093M
YoY Change -59.96% -26.85% -45.16%
% of Gross Profit
Research & Development $796.3K $1.106M $1.580M
YoY Change -13.03% 105.6% 182.99%
% of Gross Profit
Depreciation & Amortization $76.02K $76.02K $75.06K
YoY Change -64.99% -68.8% -76.31%
% of Gross Profit
Operating Expenses $2.797M $4.458M $4.749M
YoY Change -53.13% -14.81% -27.12%
Operating Profit -$2.759M -$4.420M
YoY Change -53.23% -12.78%
Interest Expense -$282.1K $223.0K $696.0K
YoY Change -38.57% -743.76% -11956.9%
% of Operating Profit
Other Income/Expense, Net $7.476M $0.00 $1.690K
YoY Change -100.0% -84.65%
Pretax Income -$10.90M -$5.220M -$6.012M
YoY Change 71.36% 2.37% -13.01%
Income Tax $3.255K $6.620K
% Of Pretax Income
Net Earnings -$10.68M -$5.222M -$6.022M
YoY Change 62.47% -1.48% -12.97%
Net Earnings / Revenue -26696.39% -13795.68% -2264.4%
Basic Earnings Per Share
Diluted Earnings Per Share -$2.10 -$0.21 -$0.24
COMMON SHARES
Basic Shares Outstanding 25.86M shares 25.03M shares 25.03M shares
Diluted Shares Outstanding 5.066M shares 25.33M shares

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $5.982M $1.588M $3.237M
YoY Change -40.05% -88.49% -46.39%
Cash & Equivalents $5.982M $1.588M $3.237M
Short-Term Investments
Other Short-Term Assets $772.9K $425.0K $729.3K
YoY Change -56.55% -31.9% 22.04%
Inventory
Prepaid Expenses
Receivables $42.13K $55.39K $261.8K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $6.797M $2.133M $4.347M
YoY Change -42.38% -85.78% -37.25%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill $4.183M $4.183M $4.183M
YoY Change 0.0%
Intangibles $414.2K $490.2K $566.3K
YoY Change -76.2%
Long-Term Investments
YoY Change
Other Assets $250.4K
YoY Change 261.83%
Total Long-Term Assets $4.597M $4.697M $5.027M
YoY Change -29.98% -32.08% -27.17%
TOTAL ASSETS
Total Short-Term Assets $6.797M $2.133M $4.347M
Total Long-Term Assets $4.597M $4.697M $5.027M
Total Assets $11.39M $6.830M $9.374M
YoY Change -37.95% -68.84% -32.22%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $871.0K $666.7K $623.1K
YoY Change 39.66% -3.83% 4.98%
Accrued Expenses $359.7K $1.205M $530.9K
YoY Change -69.02% -0.62% -62.61%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00
YoY Change -100.0%
Total Short-Term Liabilities $1.290M $1.963M $1.249M
YoY Change -57.38% -33.9% -57.43%
LONG-TERM LIABILITIES
Long-Term Debt $216.2K $8.443M $7.842M
YoY Change -97.16% 13.11%
Other Long-Term Liabilities $325.0K $325.0K
YoY Change
Total Long-Term Liabilities $541.2K $8.768M $7.842M
YoY Change -92.89% 17.46%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.290M $1.963M $1.249M
Total Long-Term Liabilities $541.2K $8.768M $7.842M
Total Liabilities $1.831M $10.73M $9.091M
YoY Change -82.78% 2.84% 209.79%
SHAREHOLDERS EQUITY
Retained Earnings -$156.0M -$145.4M -$140.1M
YoY Change 20.91%
Common Stock $786.00 $2.587K $140.3M
YoY Change 10.8%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $9.563M -$3.901M $283.5K
YoY Change
Total Liabilities & Shareholders Equity $11.39M $6.830M $9.374M
YoY Change -37.95% -68.84% -32.22%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q4
OPERATING ACTIVITIES
Net Income -$10.68M -$5.222M -$6.022M
YoY Change 62.47% -1.48% -12.97%
Depreciation, Depletion And Amortization $76.02K $76.02K $75.06K
YoY Change -64.99% -68.8% -76.31%
Cash From Operating Activities -$2.000M -$2.170M -$2.973M
YoY Change -40.84% -30.04% -8.22%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00 -$950.00
YoY Change -100.0% -100.0% -92.87%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities $0.00 $960.00
YoY Change -100.0% -107.2%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 6.384M $543.8K -662.0K
YoY Change -31918300.0% -94.98% -1348.11%
NET CHANGE
Cash From Operating Activities -2.000M -$2.170M -2.973M
Cash From Investing Activities 0.000 960.0
Cash From Financing Activities 6.384M $543.8K -662.0K
Net Change In Cash 4.383M -$1.649M -3.634M
YoY Change -228.51% -121.34% 13.58%
FREE CASH FLOW
Cash From Operating Activities -$2.000M -$2.170M -$2.973M
Capital Expenditures $0.00 $0.00 -$950.00
Free Cash Flow -$2.000M -$2.170M -$2.972M
YoY Change -40.31% -30.03% -7.87%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
23563852 shares
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
001-40747
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
authID Inc.
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
46-2069547
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
1385 S. Colorado Blvd
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Denver
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
CO
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
80222
CY2023Q1 dei City Area Code
CityAreaCode
516
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
274-8700
CY2023Q1 dei Security12b Title
Security12bTitle
Common Stock par value $0.0001 per share
CY2023Q1 dei Trading Symbol
TradingSymbol
AUID
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2023Q1 dei Entity Ex Transition Period
EntityExTransitionPeriod
true
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
25864437 shares
CY2023Q1 us-gaap Cash
Cash
1587982 usd
CY2022Q4 us-gaap Cash
Cash
3237106 usd
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
55391 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
261809 usd
CY2023Q1 us-gaap Other Assets Current
OtherAssetsCurrent
425024 usd
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
729342 usd
CY2023Q1 us-gaap Assets Held In Trust Current
AssetsHeldInTrustCurrent
64671 usd
CY2022Q4 us-gaap Assets Held In Trust Current
AssetsHeldInTrustCurrent
118459 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
2133068 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
4346716 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
250383 usd
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
490242 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
566259 usd
CY2023Q1 us-gaap Goodwill
Goodwill
4183232 usd
CY2022Q4 us-gaap Goodwill
Goodwill
4183232 usd
CY2023Q1 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
23685 usd
CY2022Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
27595 usd
CY2023Q1 us-gaap Assets
Assets
6830227 usd
CY2022Q4 us-gaap Assets
Assets
9374185 usd
CY2023Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1871443 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1154072 usd
CY2023Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
73869 usd
CY2022Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
81318 usd
CY2023Q1 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
17795 usd
CY2022Q4 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
13759 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
1963107 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1249149 usd
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
458800 usd
CY2023Q1 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
7983896 usd
CY2022Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
7841500 usd
CY2023Q1 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
325000 usd
CY2023Q1 us-gaap Liabilities
Liabilities
10730803 usd
CY2022Q4 us-gaap Liabilities
Liabilities
9090649 usd
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
25864437 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
25864437 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
25319095 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
25319095 shares
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
2587 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
2532 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
141317627 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
140255234 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-145352653 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-140130159 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
131863 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
155929 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-3900576 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
283536 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6830227 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
9374185 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
35778 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
35493 usd
CY2023Q1 auid Legacy Authentication Services
LegacyAuthenticationServices
2078 usd
CY2022Q1 auid Legacy Authentication Services
LegacyAuthenticationServices
129559 usd
CY2023Q1 us-gaap Revenues
Revenues
37856 usd
CY2022Q1 us-gaap Revenues
Revenues
165052 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3276191 usd
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3643909 usd
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1105814 usd
CY2022Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1373502 usd
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
76017 usd
CY2022Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
215476 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
4458022 usd
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
5232887 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-4420166 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-5067835 usd
CY2023Q1 us-gaap Interest Expense Other Long Term Debt
InterestExpenseOtherLongTermDebt
800073 usd
CY2022Q1 us-gaap Interest Expense Other Long Term Debt
InterestExpenseOtherLongTermDebt
32857 usd
CY2022Q1 us-gaap Other Income
OtherIncome
1456 usd
CY2023Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-800073 usd
CY2022Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-31401 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5220239 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5099236 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4972 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-5220239 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-5104208 usd
CY2023Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-2255 usd
CY2022Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-196520 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-5222494 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-5300728 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.21
CY2022Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.22
CY2023Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0
CY2022Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.01
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
25325154 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
23563852 shares
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-5222494 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-5300728 usd
CY2023Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-24066 usd
CY2022Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
32740 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-5246560 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-5267988 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
10895578 usd
CY2022Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
3146940 usd
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1866989 usd
CY2022Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
91757 usd
CY2022Q1 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
303000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
449474 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-5300728 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
32740 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
11485750 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
283536 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
840021 usd
CY2023Q1 us-gaap Stock Issued During Period Value Employee Stock Ownership Plan
StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan
222427 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-5222494 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-24066 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-3900576 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-5222494 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-5300728 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
76017 usd
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
215476 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
840021 usd
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1866989 usd
CY2023Q1 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
222427 usd
CY2023Q1 us-gaap Other Noncash Expense
OtherNoncashExpense
8250 usd
CY2023Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
567287 usd
CY2022Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
12657 usd
CY2023Q1 auid Noncash Recruiting Fees
NoncashRecruitingFees
492000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-206419 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
27076 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
-106600 usd
CY2022Q1 us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
-152128 usd
CY2022Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
34104 usd
CY2023Q1 auid Conversion Of Convertible Note Payable And Accrued Interest To Common Stock
ConversionOfConvertibleNotePayableAndAccruedInterestToCommonStock
155371 usd
CY2022Q1 auid Conversion Of Convertible Note Payable And Accrued Interest To Common Stock
ConversionOfConvertibleNotePayableAndAccruedInterestToCommonStock
-373372 usd
CY2023Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-7449 usd
CY2022Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
160537 usd
CY2023Q1 auid Increase Decrease In Others Operating Liabilities
IncreaseDecreaseInOthersOperatingLiabilities
325000 usd
CY2023Q1 auid Discontinued Operations
DiscontinuedOperations
60494 usd
CY2022Q1 auid Discontinued Operations
DiscontinuedOperations
225769 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2170057 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3101724 usd
CY2022Q1 auid Reclass From Current Assets To Other Assets
ReclassFromCurrentAssetsToOtherAssets
450 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-450 usd
CY2023Q1 us-gaap Proceeds From Debt Net Of Issuance Costs
ProceedsFromDebtNetOfIssuanceCosts
543760 usd
CY2022Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
3146940 usd
CY2022Q1 us-gaap Proceeds From Repayments Of Bank Overdrafts
ProceedsFromRepaymentsOfBankOverdrafts
7992841 usd
CY2022Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
300000 usd
CY2022Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
1579 usd
CY2022Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
10562 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
543760 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
10827640 usd
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-22505 usd
CY2022Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
32323 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1648802 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
7757789 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3237106 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5767276 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Disposal Group Including Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations
2703 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Disposal Group Including Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations
270707 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Disposal Group Including Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations
3025 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Disposal Group Including Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations
337660 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1587982 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
13458112 usd
CY2022Q1 us-gaap Interest Paid
InterestPaid
7188 usd
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
4388 usd
CY2022Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
11739 usd
CY2023Q1 us-gaap Interest Paid Discontinued Operations
InterestPaidDiscontinuedOperations
1294 usd
CY2022Q1 us-gaap Interest Paid Discontinued Operations
InterestPaidDiscontinuedOperations
1149 usd
CY2022Q1 auid Cashless Option And Warrant Exercises
CashlessOptionAndWarrantExercises
19 usd
CY2022Q1 auid Conversions Of Convertible Note Payable And Accrued Interest To Common Stock
ConversionsOfConvertibleNotePayableAndAccruedInterestToCommonStock
91757 usd
CY2022Q1 auid Common Stock For Working Capital Facility
CommonStockForWorkingCapitalFacility
303000 usd
CY2022Q1 auid Warrant For Services With The Issuance Of Convertible Debt
WarrantForServicesWithTheIssuanceOfConvertibleDebt
449474 usd
CY2023Q1 auid Accumulated Deficit
AccumulatedDeficit
145000000 usd
CY2023Q1 us-gaap Revenues And Gains Reporting Currency Denominated Value
RevenuesAndGainsReportingCurrencyDenominatedValue
40000.00 usd
CY2023Q1 auid Loss From Opration
lossFromOpration
2200000 usd
CY2023Q1 auid Net Loss Of Approximately
NetLossOfApproximately
5300000 usd
CY2023Q1 auid Additional Financing
AdditionalFinancing
3600000 usd
CY2022Q4 us-gaap Prepaid Insurance
PrepaidInsurance
244215 usd
CY2023Q1 us-gaap Long Term Debt
LongTermDebt
174838 usd
CY2023Q1 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Reclassification </i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span>Certain prior year expenses have been reclassified for consistency with the current year presentation. These reclassifications had no effect on the previously reported loss from continuing operations and management does not believe that this reclassification is material to the consolidated financial statements taken as a whole. Specifically, we reclassified certain expenses from general and administrative expenses to research and development expenses.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i> </i></p>
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
11641187 shares
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
13294541 shares
CY2023Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
74000 usd
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
81000 usd
CY2023Q1 us-gaap Prepaid Insurance
PrepaidInsurance
100186 usd
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
135405 usd
CY2022Q4 auid Unamortized Credit Facility Fees
UnamortizedCreditFacilityFees
199156 usd
CY2023Q1 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
150000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
150566 usd
CY2023Q1 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
425024 usd
CY2022Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
729342 usd
CY2022Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
248945 usd
CY2022Q4 us-gaap Income Tax Receivable
IncomeTaxReceivable
1438 usd
CY2022Q4 us-gaap Other Assets
OtherAssets
250383 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
566259 usd
CY2023Q1 us-gaap Adjustment For Amortization
AdjustmentForAmortization
76017 usd
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
490242 usd
CY2023Q1 us-gaap Cost Of Goods And Services Sold Amortization
CostOfGoodsAndServicesSoldAmortization
4640885 usd
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
4150643 usd
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
490242 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Rolling Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearThree
76000 usd
CY2022Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Rolling Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearThree
215000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
177063 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
168094 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
63791 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
16456 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
16456 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
48382 usd
CY2023Q1 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
490242 usd
CY2023Q1 auid Amended Amount
AmendedAmount
3600000 usd
CY2023Q1 us-gaap Advance Royalties
AdvanceRoyalties
900000 usd
CY2023Q1 us-gaap Accounts Payable Trade Current And Noncurrent
AccountsPayableTradeCurrentAndNoncurrent
666691 usd
CY2022Q4 us-gaap Accounts Payable Trade Current And Noncurrent
AccountsPayableTradeCurrentAndNoncurrent
623130 usd
CY2023Q1 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
325000 usd
CY2022Q4 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
145837 usd
CY2023Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
879752 usd
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
385105 usd
CY2023Q1 us-gaap Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
1871443 usd
CY2022Q4 us-gaap Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
1154072 usd
CY2023Q1 us-gaap Severance Costs1
SeveranceCosts1
800000 usd
CY2023Q1 auid Severance Expenses Amount Paid
SeveranceExpensesAmountPaid
200000 usd
CY2023Q1 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
300000 usd
CY2023Q1 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
300000 usd
CY2022Q1 us-gaap Line Of Credit Facility Annual Principal Payment
LineOfCreditFacilityAnnualPrincipalPayment
10000000 usd
CY2022Q1 us-gaap Shares Issued
SharesIssued
100000 shares
CY2023Q1 auid Initial Credit Facility
InitialCreditFacility
900000 usd
CY2023Q1 auid Aggregate Amount
AggregateAmount
2700000 usd
CY2023Q1 us-gaap Line Of Credit Facility Annual Principal Payment
LineOfCreditFacilityAnnualPrincipalPayment
900000 usd
CY2023Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
410000 usd
CY2023Q1 auid Capitalized Issuance Costs
CapitalizedIssuanceCosts
426000 usd
CY2023Q1 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
449000 usd
CY2023Q1 auid Interest Accrues Per Annum Rate Percentage
InterestAccruesPerAnnumRatePercentage
0.15 pure
CY2023Q1 auid Principal Amounts Maturity Date
PrincipalAmountsMaturityDate
2025-03-31
CY2022Q1 auid Interest Accrues Per Annum Rate Percentage
InterestAccruesPerAnnumRatePercentage
0.12 pure
CY2023Q1 auid Secured Facility Amount
SecuredFacilityAmount
2700000 usd
CY2023Q1 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
375000 usd
CY2023Q1 us-gaap Share Based Goods And Nonemployee Services Transaction Modification Of Terms Incremental Compensation Cost
ShareBasedGoodsAndNonemployeeServicesTransactionModificationOfTermsIncrementalCompensationCost
1000000 usd
CY2023Q1 auid Aggregate Amount
AggregateAmount
5000000 usd
CY2023Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
1115000 shares
CY2023Q1 us-gaap Common Stock Dividends Shares
CommonStockDividendsShares
1465000 shares
CY2023Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
0.33 usd
CY2023Q1 us-gaap Line Of Credit Facility Periodic Payment
LineOfCreditFacilityPeriodicPayment
900000 usd
CY2023Q1 auid Accrued Interest
AccruedInterest
8250 usd
CY2023Q1 auid Unamortized Debt Issuance Costs
UnamortizedDebtIssuanceCosts
-449450 usd
CY2023Q1 us-gaap Line Of Credit Facility Increase Decrease For Period Net
LineOfCreditFacilityIncreaseDecreaseForPeriodNet
458800 usd
CY2022Q1 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
9200000 usd
CY2022Q1 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
3.7
CY2022Q1 us-gaap Payments For Origination Of Mortgage Loans Held For Sale
PaymentsForOriginationOfMortgageLoansHeldForSale
200000 usd
CY2022Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
28500 shares
CY2022Q1 us-gaap Investment Interest Rate
InvestmentInterestRate
0.0975 pure
CY2023Q1 us-gaap Debt Instrument Maturity Date
DebtInstrumentMaturityDate
2025-03-31
CY2023Q1 us-gaap Shares Issued
SharesIssued
545342 shares
CY2022Q1 us-gaap Shares Issued
SharesIssued
0 shares
CY2022Q1 us-gaap Investment Owned Balance Principal Amount
InvestmentOwnedBalancePrincipalAmount
0 usd
CY2023Q1 us-gaap Common Stock Other Shares Outstanding
CommonStockOtherSharesOutstanding
142690 shares
CY2023Q1 us-gaap Common Stock Other Value Outstanding
CommonStockOtherValueOutstanding
449000 usd
CY2023Q1 auid Convertible Notes Percentage
ConvertibleNotesPercentage
0.0975 pure
CY2023Q1 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
-180865 usd
CY2023Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
960444 usd
CY2023Q1 us-gaap Regulated Entity Other Assets Noncurrent
RegulatedEntityOtherAssetsNoncurrent
7983896 usd
CY2022Q1 us-gaap Unsecured Debt
UnsecuredDebt
10000000 usd
CY2022Q1 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
100000 shares
CY2023Q1 us-gaap Interest Expense
InterestExpense
223000 usd
CY2022Q1 us-gaap Excess Stock Shares Issued
ExcessStockSharesIssued
1063514 shares
CY2022Q1 us-gaap Excess Stock Shares Issued
ExcessStockSharesIssued
1063514 shares
CY2022Q1 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
3.03
CY2022Q1 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
3.7
CY2022Q1 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
3300000 usd
CY2022Q1 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
3300000 usd
CY2023Q1 auid Common Stock Warrants
CommonStockWarrants
1229226 usd
CY2023Q1 auid Per Share Price
PerSharePrice
4.62
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P2Y8M12D
CY2023Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
3 pure
CY2023Q1 us-gaap Shares Held In Employee Stock Option Plan Allocated
SharesHeldInEmployeeStockOptionPlanAllocated
100000 shares
CY2023Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.33
CY2023Q1 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
7945664 shares
CY2023Q1 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P3Y10M24D
CY2023Q1 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
5753389 shares
CY2023Q1 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
800000 usd
CY2023Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
6600000 usd
CY2022Q3 auid Sale Of Card Plus
SaleOfCardPlus
300000 usd
CY2022Q3 auid Card Plus Amount Received
CardPlusAmountReceived
150000 usd
CY2022Q3 auid Other Current Asset
OtherCurrentAsset
150000 usd
CY2022Q3 auid Cost Of Sale
CostOfSale
3272 usd
CY2022Q3 us-gaap Gain Loss On Fair Value Hedges Recognized In Earnings
GainLossOnFairValueHedgesRecognizedInEarnings
188247 usd
CY2023Q1 auid Conversions Of Convertible Note Payable And Accrued Interest To Common Stock
ConversionsOfConvertibleNotePayableAndAccruedInterestToCommonStock
usd
CY2023Q1 auid Common Stock For Working Capital Facility
CommonStockForWorkingCapitalFacility
usd
CY2023Q1 auid Warrant For Services With The Issuance Of Convertible Debt
WarrantForServicesWithTheIssuanceOfConvertibleDebt
usd
CY2023Q1 auid Unamortized Credit Facility Fees
UnamortizedCreditFacilityFees
usd
CY2023Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
usd
CY2023Q1 us-gaap Income Tax Receivable
IncomeTaxReceivable
usd
CY2023Q1 us-gaap Other Assets
OtherAssets
usd
CY2022 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
2500 usd
CY2022Q3 us-gaap Lease Cost
LeaseCost
1500 usd
CY2023Q1 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
5000 usd
CY2022Q1 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
21000 usd
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
usd
CY2022Q4 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
usd
CY2023Q1 us-gaap Other Income
OtherIncome
usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.21
CY2023Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.00
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised Net Of Tax Benefit Expense
StockIssuedDuringPeriodValueStockOptionsExercisedNetOfTaxBenefitExpense
usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
usd
CY2022Q1 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
usd
CY2022Q1 us-gaap Other Noncash Expense
OtherNoncashExpense
usd
CY2022Q1 auid Noncash Recruiting Fees
NoncashRecruitingFees
usd
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
usd
CY2022Q1 auid Increase Decrease In Others Operating Liabilities
IncreaseDecreaseInOthersOperatingLiabilities
usd
CY2023Q1 auid Reclass From Current Assets To Other Assets
ReclassFromCurrentAssetsToOtherAssets
usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
CY2022Q1 us-gaap Proceeds From Debt Net Of Issuance Costs
ProceedsFromDebtNetOfIssuanceCosts
usd
CY2023Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
usd
CY2023Q1 us-gaap Proceeds From Repayments Of Bank Overdrafts
ProceedsFromRepaymentsOfBankOverdrafts
usd
CY2023Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
usd
CY2023Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
usd
CY2023Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
usd
CY2023Q1 us-gaap Interest Paid
InterestPaid
usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2023Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
CY2023Q1 auid Cashless Option And Warrant Exercises
CashlessOptionAndWarrantExercises
usd
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001534154

Files In Submission

Name View Source Status
0001213900-23-038588-index-headers.html Edgar Link pending
0001213900-23-038588-index.html Edgar Link pending
0001213900-23-038588.txt Edgar Link pending
0001213900-23-038588-xbrl.zip Edgar Link pending
auid-20230331.xsd Edgar Link pending
f10q0323ex21-1_authidinc.htm Edgar Link pending
f10q0323ex31-1_authidinc.htm Edgar Link pending
f10q0323ex31-2_authidinc.htm Edgar Link pending
f10q0323ex32-1_authidinc.htm Edgar Link pending
f10q0323_authidinc.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
image_001.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
auid-20230331_cal.xml Edgar Link unprocessable
auid-20230331_pre.xml Edgar Link unprocessable
auid-20230331_def.xml Edgar Link unprocessable
auid-20230331_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
f10q0323_authidinc_htm.xml Edgar Link completed
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending